Research

Adherence

Personalized Type 2 Diabetes management, which tailors pharmacotherapy to individual phenotypic, clinical, and personal factors, improves medication adherence, patient satisfaction, and health outcomes compared to rigid algorithmic approaches.

Work with your doctor to build a treatment plan that fits your specific health profile (like kidney or heart status) and your personal life (like fear of hypoglycemia or preference for pills vs. injections). This collaborative approach leads to better adherence and fewer complications than following a generic, one-size-fits-all checklist.

GoodSupportsHIGH confidence
The use of a personalized approach in the management of people with T2D can reduce the cost and failure associated with the algorithmic “one-size-fits-all” approach, to anticipate disease progression, improve the response to diabetes pharmacotherapy and reduce the incidence of diabetes-associated complications. Ultimately, the use of personalized medicine in people with T2D should improve medication adherence, patient satisfaction and quality of life to reduce diabetes distress and improve physical health outcomes.
David M. Williams et al. · Dove Medical Press (Taylor and Francis Group) · 2022

Why this rating

The paper is a review citing multiple guidelines (ADA, EASD) and observational studies, though it notes a lack of large-scale randomized trials specifically for the 'personalized' construct itself.

Source

Personalized Type 2 Diabetes Management: An Update on Recent Advances and Recommendations

David M. Williams et al. · Dove Medical Press (Taylor and Francis Group) · 2022

narrative_reviewCited 102×
Read the paper

This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →